Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

FHS
March 11, 2024
12:55 pm

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics.

Prenatal Genetic Test Predicts Baby’s Traits as Early as 10 Weeks

What You Should Know: – BillionToOne (BTO), a company dedicated to accessible and accurate genetic testing, has launched BabyPeek, a first-of-its-kind prenatal test uses advanced

March 21, 2024

What in the world has happened since COP27? – Pharmaceutical Technology

After COP27 the European Union introduced a new plan. Credit: Alexandros Michailidis via Shutterstock. The world is currently at an environmental crisis point with climate

November 8, 2023

Agilent to lay off about 400 workers amid site closures

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Agilent Technologies, a maker of

December 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.